Skip to content
← Clinical Cases

Pharmacogenomics — clinical cases

29 questions

Sample cases

  1. Case 1

    A 47-year-old woman has a pharmacogenomic panel showing CYP2D6 *4/*41. The laboratory report lists the allele activity values as *4 = 0 (no function) and *41 = 0.5 (decreased function).

    Using the CPIC activity-score system, which CYP2D6 phenotype should be assigned?

    • A.Poor metabolizer
    • B.Intermediate metabolizer
    • C.Normal metabolizer
    • D.Indeterminate metabolizer
  2. Case 2

    A 52-year-old man with knee osteoarthritis is prescribed tramadol 50 mg every 6 hours as needed. His pharmacogenomic report shows CYP2D6 *1/*1xN (more than two copies of a normal-function allele; activity score greater than 2.25). He takes no other medicines.

    According to CPIC, what is the most appropriate recommendation?

    • A.Give tramadol at half the usual dose because he converts it faster
    • B.Change tramadol to codeine 30 mg every 6 hours as needed
    • C.Use tramadol at the usual label dose because he will get better analgesia
    • D.Avoid tramadol; use a non-opioid analgesic, or if an opioid is warranted, a non-codeine opioid
  3. Case 3

    A 30-year-old man needs short-term analgesia after a wisdom-tooth extraction. The dentist wants to prescribe acetaminophen with codeine. A pre-emptive genotype shows CYP2D6 *1/*10. Allele values: *1 = 1 (normal function), *10 = 0.25 (decreased function). He has no other relevant history.

    According to CPIC, which recommendation fits his result?

    • A.Codeine may be used at the label-recommended adult dose
    • B.Avoid codeine because he is an intermediate metabolizer
    • C.Avoid codeine because he is an ultrarapid metabolizer
    • D.Use codeine at half the label-recommended adult dose